Salesforce.com to B...
Health Care: Drugs
Abraxis BioScience Inc. (ABII: NASDAQ)
$78.25 -0.05 | -0.06%
10/15/10 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| ABII | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 18.40 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 4.33 | 107.39 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 4.00 | 0.00 | 0.00 |
| Net Income | 0.00 | 0.00 | |
| EPS | 0.00 | 0.00 |
Earnings for ABII:
| EBITDA | -42.00 |
| REVENUE | 359.05M |
Average Earnings Estimates
| Qtr (06/10) | Qtr (09/10) | FY (12/10) | FY (12/11) | |
|---|---|---|---|---|
| Average Estimate | $n.a. | $n.a. | $n.a. | $n.a. |
| Number of Analysts | 0 | 0 | 0 | 0 |
| High Estimate | $n.a. | $n.a. | $n.a. | $n.a. |
| Low Estimate | $n.a. | $n.a. | $n.a. | $n.a. |
| Prior Year | $-0.58 | $-0.69 | $-1.16 | $n.a. |
| Growth Rate (Year over Year) | n.a.% | n.a.% | n.a.% | n.a.% |
Portfolios with ABII
- Portfolio NameUser Type
- UserPART 4 JPMorgan 28th Annual...
- UserLast Day of the JPMorgan He...
- UserTop Year End NASDAQ Short S...
- UserNASDAQ Short Squeeze Plays ...
- UserTop Biotech Short Squeeze P...
- Usercowgirl09 Portfolio 1
- UserPharma1
- Userhi52052 Portfolio 1
- UserClass of '09' Portfolio 1
Latest ABII Headlines from TheStreet
- Top 12 Most Big-Hearted Billionaires 12.09.10 | 01:12 pm
- Celgene Beats and Raises Guidance 07.29.10 | 07:07 am
- Business Highlights 06.30.10 | 06:06 pm
- Celgene Acquires Abraxis for $2.9 Billion 06.30.10 | 06:06 am
- TSC Ratings' Updates: Abraxis BioScience 03.18.09 | 04:03 pm
- Mad About Options: Cubist Pharma Flashback
03.03.09 | 01:03 pm - Mad About Options: Cubist Pharma 01.05.09 | 01:01 pm
- Mad About Options: Cubist Pharma 11.03.08 | 08:11 am
- Biotech-Stock Mailbag: Sangamo 06.13.08 | 06:06 am
Press Releases for ABII
- Celgene And Abraxis Announce Shareholder Vote In Favor Of Merger - Business Wire 10.13.10 | 04:10 pm
- Abraxis BioScience And Specialised Therapeutics Announce Approval To Market ABRAXANE For Metastatic Breast Cancer In New Zealand - Business Wire 07.29.10 | 05:07 am
- ABRAXANE® Approved For Marketing In Japan For Breast Cancer - Business Wire 07.23.10 | 09:07 am
- Bull & Lifshitz, LLP Announces Investigation Of The Acquisition Of Abraxis BioScience Inc. - Business Wire 07.19.10 | 04:07 pm
- Faruqi & Faruqi, LLP Investigates Potential Breaches Of Fiduciary Duties By The Board Of Abraxis BioSciences, Inc. - ABII - Business Wire 07.12.10 | 05:07 pm
- The Law Office Of Joseph Klein Investigates Possible Breach Of Fiduciary Duty By The Board Of Abraxis BioSciences Inc. - ABII - Business Wire 07.07.10 | 07:07 pm
- Wolf Haldenstein Investigates Abraxis Bioscience, Inc. Proposed Acquisition - Business Wire 07.02.10 | 11:07 am
- Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of Abraxis BioScience, Inc. - Business Wire 06.30.10 | 09:06 pm
- Robbins Umeda LLP Announces An Investigation Of The Acquisition Of Abraxis BioScience Inc. By Celgene Corporation - Business Wire 06.30.10 | 08:06 pm
- Finkelstein Thompson LLP Announces Investigation Of Abraxis Bioscience Inc. - Business Wire 06.30.10 | 06:06 pm
Partner Headlines for ABII
- Celgene and Abraxis Shareholders Vote in Favor of Merger - Benzinga 10.13.10 | 04:10 pm
- Natco Challenges Celgene's Revlimid - Analyst Blog - Zacks 09.06.10 | 10:09 am
- Generic Threat Hanging Over CELG - Analyst Blog - Zacks 08.27.10 | 09:08 am
- Celgene's Revlimid Marches on - Analyst Blog - Zacks 08.20.10 | 04:08 pm
- Celgene Evenly Poised - Analyst Blog - Zacks 08.17.10 | 05:08 pm
- Companies Give Back Q1 Gains - What Could Spark Q3? - Seeking Alpha 07.19.10 | 07:07 am
- Stocks Hitting 52-Week Highs (ABII, ADCT, BRCM, ERES) - Benzinga 07.13.10 | 01:07 pm
- Merger Arbitrage Mondays: July 05, 2010 - Seeking Alpha 07.05.10 | 09:07 am
- Piper Jaffray Overweight on Celgene Corporation (CELG) - Benzinga 07.02.10 | 04:07 pm
- Jefferies Raises Estimates on Celgene Corp. (CELG, ABII) - Benzinga 07.01.10 | 09:07 am
